Literature DB >> 32467248

Methotrexate reduces withdrawal rates of TNF inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive.

Mandy Greenwood1, Muhammad Shipa1, Su-Ann Yeoh1, Euthalia Roussou2, Dev Mukerjee3, Michael R Ehrenstein4.   

Abstract

Entities:  

Keywords:  anti-citrullinated protein antibodies; arthritis, rheumatoid; methotrexate; rheumatoid factor; tumor necrosis factor inhibitors

Mesh：

Substances：

Year:  2020        PMID： 32467248     DOI： 10.1136/annrheumdis-2020-217725

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  2 in total

Review 1.  The Genetic, Environmental, and Immunopathological Complexity of Autoantibody-Negative Rheumatoid Arthritis.

Authors:  Ludovico De Stefano; Bernardo D'Onofrio; Antonio Manzo; Carlomaurizio Montecucco; Serena Bugatti
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

2.  Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis.

Authors:  Borja Hernández-Breijo; Claudia M Brenis; Chamaida Plasencia-Rodríguez; Ana Martínez-Feito; Marta Novella-Navarro; Dora Pascual-Salcedo; Alejandro Balsa
Journal:  Front Med (Lausanne)       Date:  2021-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.